Expression of MT-ND3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

MT-ND3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 7574.44

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

7537.3

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	26470.2
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	20570.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	20116.3
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	19729.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	18178.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	17526.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	16211.5
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	15365.4
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	15353.6
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	14654.5
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	14389.7
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	13718.6
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	13284.9
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	13070.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	12848.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	12793.2
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	12207.7
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	11803.9
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	11456.5
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	11110.2
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	10885.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	10523.8
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	10466.5
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	10271.4
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	10211.4
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	10149.9
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	10078.8
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	9996.9
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	9448.5
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	9441.1
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	9428.8
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	9361.8
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	9254.0
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	9206.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	9167.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	9010.7
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	8790.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	8684.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	8649.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	8620.0
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	8561.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	8521.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	8340.1
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	8160.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	8140.4
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	8139.1
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	8128.0
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	8118.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	8033.8
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	7985.3
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	7983.4
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	7930.7
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	7895.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	7874.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	7833.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	7801.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	7799.8
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	7748.1
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	7671.7
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	7593.4
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	7589.2
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	7579.6
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	7574.4
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	7559.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	7411.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	7393.3
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	7335.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	7178.6
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	7169.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	7042.7
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	7029.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	6905.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	6790.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	6741.8
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	6662.7
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	6655.8
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	6593.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	6569.2
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	6464.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	6435.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	6256.2
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	6022.6
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	5973.8
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	5917.6
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	5765.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	5757.8
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	5700.5
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	5683.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	5664.8
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	5580.8
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	5550.7
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	5520.6
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	5379.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	5312.4
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	5283.7
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	5219.3
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	5151.3
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	5127.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	5117.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	5114.4
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	5052.6
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	5046.0
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	4980.9
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	4955.5
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	4954.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	4923.1
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	4895.6
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	4866.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	4674.0
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	4609.1
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	4495.7
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	4315.8
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	4215.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	4203.5
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	4172.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	4003.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	3948.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3907.8
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3865.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	3691.2
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	3561.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3453.5
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	3330.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3279.1
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	3258.9
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	3128.5
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	3127.9
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2933.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2925.3
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2920.0
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2810.3
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2742.6
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2720.7
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2607.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2478.6
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2443.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2391.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2212.3
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2128.4
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2036.8
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1958.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

MT-ND3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3223.4

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2328.2

Number of samples

Samples

Sample	Description	pTPM
AK006	N, NA, stage:NA, dead, 360 days	10990.1
AK218	N, NA, stage:NA, dead, 180 days	7499.4
AK002	N, NA, stage:NA, dead, 570 days	5166.4
AK167	N, NA, stage:NA, dead, 180 days	5151.9
AK005	N, NA, stage:NA, dead, 240 days	4762.9
AK205	N, NA, stage:NA, dead, 120 days	4114.3
AK081	N, NA, stage:NA, dead, 180 days	4096.3
AK134	N, NA, stage:NA, dead, 360 days	4050.5
AK158	N, NA, stage:NA, dead, 360 days	3964.4
AK091	N, NA, stage:NA, dead, 210 days	3774.0
AK030	N, NA, stage:NA, dead, 120 days	3661.7
AK102	N, NA, stage:NA, alive, 1740 days	3243.1
AK099	N, NA, stage:NA, dead, 420 days	3241.7
AK015	N, NA, stage:NA, alive, 720 days	3205.1
AK226	N, NA, stage:NA, dead, 360 days	3000.2
AK043	N, NA, stage:NA, alive, 660 days	2927.8
AK035	N, NA, stage:NA, dead, 210 days	2807.1
AK227	N, NA, stage:NA, alive, 300 days	2689.2
AK133	N, NA, stage:NA, dead, 360 days	2683.5
AK173	N, NA, stage:NA, dead, 180 days	2602.0
AK117	N, NA, stage:NA, dead, 210 days	2545.6
AK124	N, NA, stage:NA, alive, 1920 days	2460.4
AK079	N, NA, stage:NA, dead, 210 days	2395.5
AK195	N, NA, stage:NA, dead, 390 days	2390.6
AK066	N, NA, stage:NA, alive, 960 days	2205.9
AK123	N, NA, stage:NA, dead, 180 days	2096.0
AK213	N, NA, stage:NA, alive, 2010 days	2048.0
AK149	N, NA, stage:NA, dead, 420 days	1865.5
AK089	N, NA, stage:NA, dead, 330 days	1798.2
AK041	N, NA, stage:NA, alive, 810 days	1762.1
AK153	N, NA, stage:NA, dead, 240 days	1693.1
AK183	N, NA, stage:NA, alive, 360 days	1670.9
AK051	N, NA, stage:NA, dead, 360 days	1605.6
AK156	N, NA, stage:NA, dead, 330 days	1559.5
AK076	N, NA, stage:NA, alive, 660 days	1491.6
AK188	N, NA, stage:NA, alive, 420 days	1444.8
AK085	N, NA, stage:NA, alive, 660 days	1413.7
AK003	N, NA, stage:NA, dead, 600 days	1275.5
AK103	N, NA, stage:NA, alive, 1320 days	1260.9
AK185	N, NA, stage:NA, alive, 330 days	1227.1
AK165	N, NA, stage:NA, alive, 360 days	1210.2
AK088	N, NA, stage:NA, dead, 360 days	1087.7
AK142	N, NA, stage:NA, alive, 90 days	1045.1
AK072	N, NA, stage:NA, dead, 150 days	997.7
AK053	N, NA, stage:NA, dead, 300 days	959.0
AK071	N, NA, stage:NA, dead, 540 days	958.3
AK236	N, NA, stage:NA, dead, 360 days	939.0
AK055	N, NA, stage:NA, dead, 240 days	927.4
AK049	N, NA, stage:NA, dead, 180 days	853.4
AK231	N, NA, stage:NA, dead, 240 days	802.8
AK199	N, NA, stage:NA, alive, 1860 days	796.1
AK068	N, NA, stage:NA, alive, 360 days	783.6
AK178	N, NA, stage:NA, dead, 240 days	758.3
AK100	N, NA, stage:NA, alive, 960 days	714.3
AK098	N, NA, stage:NA, dead, 660 days	682.1
AK074	N, NA, stage:NA, alive, 300 days	640.5
AK139	N, NA, stage:NA, dead, 270 days	581.0
AK216	N, NA, stage:NA, dead, 360 days	461.5
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA063296
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade